Annals of Surgical Oncology

The Annals of Surgical Oncology, published by Springer Nature, is a premier peer-reviewed journal and the official publication of the Society of Surgical Oncology. With an ISSN of 1068-9265 and a 2026 Impact Factor of 3.800, the journal holds a distinguished Q1 ranking in the JCR quartile system, reflecting its high citation impact and influence within the field. The journal’s scope encompasses the full spectrum of surgical oncology, including multidisciplinary management of malignant disease, with a strong emphasis on clinical trials, translational research, and evidence-based surgical techniques. Main topics covered include breast, gastrointestinal, hepatopancreatobiliary, thoracic, melanoma, sarcoma, and head and neck cancers, as well as emerging areas such as immunotherapy, precision oncology, and minimally invasive surgical innovations. The Annals publishes a variety of article types, including original research articles, comprehensive reviews, meta-analyses, editorials, and special reports on practice guidelines and consensus statements. It also features unique content such as the “How I Do It” series and video-based surgical education pieces. The target audience comprises surgical oncologists, general surgeons, medical and radiation oncologists, clinical researchers, and allied healthcare professionals dedicated to cancer care. While the journal operates under a traditional subscription model, authors have the option to publish open access for broader dissemination. Its consistent Q1 standing and robust impact factor underscore its role as a leading resource for cutting-edge developments in surgical oncology, making it an essential reference for clinicians and investigators aiming to advance patient outcomes through innovative surgical and multimodal therapies.